PPACK Dihydrochloride

PPACK Dihydrochloride

Contact us: [email protected]

PPACK II, trifluoroacetate
B2151-5
EUR 352.8

Vatalanib Dihydrochloride
2025-25
EUR 366

Vatalanib Dihydrochloride
2025-5
EUR 151.2

1400W dihydrochloride
2055-25
EUR 405.6

1400W dihydrochloride
2055-5
EUR 151.2

GGACK Dihydrochloride
1847-5 5 mg
EUR 382.8
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin.

Puromycin Dihydrochloride
1860-100
EUR 326.4

Puromycin Dihydrochloride
1860-1000
EUR 1554

Puromycin Dihydrochloride
1860-25
EUR 151.2

Puromycin Dihydrochloride
1860-250
EUR 548.4

Puromycin Dihydrochloride
1860-500
EUR 966

Emetine dihydrochloride
1970-250
EUR 430.8

Emetine dihydrochloride
1970-50
EUR 164.4

Norquetiapine dihydrochloride
2362-250
EUR 496.8

Norquetiapine dihydrochloride
2362-50
EUR 170.4

Antipain dihydrochloride
2834-25
EUR 392.4

Antipain dihydrochloride
2834-5
EUR 144

Dorsmorphin dihydrochloride
2835-25
EUR 705.6

Dorsmorphin dihydrochloride
2835-5
EUR 222

Berbamine dihydrochloride
2520-100
EUR 157.2

Berbamine dihydrochloride
2520-500
EUR 444

GGACK Dihydrochloride
A2582-5 5 mg
EUR 282
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin.

AT7867 dihydrochloride
A3199-10 10 mg
EUR 408
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

AT7867 dihydrochloride
A3199-100 100 mg
EUR 2210.4
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

AT7867 dihydrochloride
A3199-5 5 mg
EUR 320.4
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

AT7867 dihydrochloride
A3199-5.1 10 mM (in 1mL DMSO)
EUR 344.4
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

AT7867 dihydrochloride
A3199-50 50 mg
EUR 1537.2
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

Canertinib dihydrochloride
A3276-10 10 mg
EUR 129.6
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development.

Canertinib dihydrochloride
A3276-100 100 mg
EUR 226.8
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development.

Canertinib dihydrochloride
A3276-50 50 mg
EUR 177.6
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development.

Inolitazone dihydrochloride
A3499-5 5 mg
EUR 837.6
Description: Description:IC50 Value: 0.8 nM [1]Inolitazone(RS5444) is a novel high-affinity PPARgamma agonist, which activates PPARgamma with an EC50 about 1/50th that of rosiglitazone and has no effect on RIE cells that do not express PPARgamma.

Alexidine dihydrochloride
A4542-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Selective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1) (IC50 = 1.08 ?M in vitro). Stimulates increased insulin secretion by ?-cells in rat pancreatic islets. Displays antitcancer properties in FaDu cells.

Alexidine dihydrochloride
A4542-50 50 mg
EUR 220.8
Description: Selective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1) (IC50 = 1.08 ?M in vitro). Stimulates increased insulin secretion by ?-cells in rat pancreatic islets. Displays antitcancer properties in FaDu cells.

Vatalanib Dihydrochloride
20-abx076544
  • EUR 309.60
  • EUR 594.00
  • 10 mg
  • 50 mg

DMPQ Dihydrochloride
20-abx076714
  • EUR 693.60
  • EUR 326.40
  • 25 mg
  • 5 mg

H89 Dihydrochloride
20-abx076747
  • EUR 811.20
  • EUR 360.00
  • 25 mg
  • 5 mg

LDK378 dihydrochloride
A3544-10 10 mg
EUR 186
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

LDK378 dihydrochloride
A3544-100 100 mg
EUR 331.2
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

LDK378 dihydrochloride
A3544-5 5 mg
EUR 150
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

LDK378 dihydrochloride
A3544-5.1 10 mM (in 1mL H2O)
EUR 184.8
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

LDK378 dihydrochloride
A3544-50 50 mg
EUR 240
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

Mibefradil dihydrochloride
A3605-10 10 mg
EUR 315.6
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris.

Mibefradil dihydrochloride
A3605-25 25 mg
EUR 663.6
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris.

Mibefradil dihydrochloride
A3605-5 5 mg
EUR 201.6
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris.

Mibefradil dihydrochloride
A3605-50 50 mg
EUR 1195.2
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris.

Pramipexole dihydrochloride
A3733-20 20 mg
EUR 129.6
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors.

Pramipexole dihydrochloride
A3733-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors.

Pramipexole dihydrochloride
A3733-50 50 mg
EUR 157.2
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors.

Retigabine dihydrochloride
A3758-10 10 mg
EUR 164.4
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride
A3758-100 100 mg
EUR 522
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride
A3758-5 5 mg
EUR 126
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride
A3758-5.1 10 mM (in 1mL DMSO)
EUR 170.4
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride
A3758-50 50 mg
EUR 325.2
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Veliparib dihydrochloride
A3958-10 10 mg
EUR 177.6
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride
A3958-200 200 mg
EUR 1002
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride
A3958-5 5 mg
EUR 150
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride
A3958-5.1 10 mM (in 1mL DMSO)
EUR 139.2
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride
A3958-50 50 mg
EUR 421.2
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Piperazine Dihydrochloride
abx180858-100g 100 g
EUR 276

Pramipexole dihydrochloride
20-abx180860
  • EUR 543.60
  • EUR 276.00
  • EUR 444.00
  • 10 g
  • 1 g
  • 5 g

IT1t dihydrochloride
B5650-10 10 mg
EUR 385.2
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride
B5650-100 100 mg
EUR 2100
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride
B5650-25 25 mg
EUR 710.4
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride
B5650-5 5 mg
EUR 243.6
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride
B5650-5.1 10 mM (in 1mL DMSO)
EUR 261.6
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride
B5650-50 50 mg
EUR 1232.4
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

Cystamine dihydrochloride
B5785-5.1 10 mM (in 1mL DMSO)
EUR 129.6

Cystamine dihydrochloride
B5785-50 50 mg
EUR 134.4

Fluphenazine dihydrochloride
B6132-100 100 mg
EUR 180
Description: EC50: 1.24 ?MFluphenazine is a dopamine D1 and D2 receptor inhibitor.Dopamine D1 and D2 receptor immunohistochemistry has been used to study the structure of the adult rat arcuate-median eminence complex, particularly in relation to the tubero-infundibular dopamine neurons.

Fluphenazine dihydrochloride
B6132-5.1 10 mM (in 1mL DMSO)
EUR 201.6
Description: EC50: 1.24 ?MFluphenazine is a dopamine D1 and D2 receptor inhibitor.Dopamine D1 and D2 receptor immunohistochemistry has been used to study the structure of the adult rat arcuate-median eminence complex, particularly in relation to the tubero-infundibular dopamine neurons.

Dilazep dihydrochloride
B6316-50 50 mg
EUR 321.6

Dimaprit dihydrochloride
B6328-100 100 mg
EUR 321.6

Naloxonazine dihydrochloride
B6366-10 10 mg
EUR 265.2

Naloxonazine dihydrochloride
B6366-50 50 mg
EUR 926.4

Piribedil dihydrochloride
B6557-10 10 mg
EUR 166.8

Piribedil dihydrochloride
B6557-100 100 mg
EUR 258

Piribedil dihydrochloride
B6557-200 200 mg
EUR 404.4

Piribedil dihydrochloride
B6557-5.1 10 mM (in 1mL DMSO)
EUR 180

Piribedil dihydrochloride
B6557-50 50 mg
EUR 223.2

Piribedil dihydrochloride
B6557-500 500 mg
EUR 675.6

Pirenzepine dihydrochloride
B6582-100 100 mg
EUR 160.8

Pirenzepine dihydrochloride
B6582-5.1 10 mM (in 1mL DMSO)
EUR 180

Pirenzepine dihydrochloride
B6582-500 500 mg
EUR 219.6

Telenzepine dihydrochloride
B6606-10 10 mg
EUR 193.2

Telenzepine dihydrochloride
B6606-50 50 mg
EUR 576

DMPQ dihydrochloride
B6642-10 10 mg
EUR 223.2

DMPQ dihydrochloride
B6642-5 5 mg
EUR 184.8

GNTI dihydrochloride
B6669-10 10 mg
EUR 459.6

GNTI dihydrochloride
B6669-50 50 mg
EUR 1746

1400W dihydrochloride
B6730-10 10 mg
EUR 170.4
Description: 1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase with Kd value of 7 nM [1]. Inducible nitric oxide synthase (iNOS) is an enzyme catalyzing the production of nitric oxide (NO) and is involved in immune response.

1400W dihydrochloride
B6730-100 100 mg
EUR 873.6
Description: 1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase with Kd value of 7 nM [1]. Inducible nitric oxide synthase (iNOS) is an enzyme catalyzing the production of nitric oxide (NO) and is involved in immune response.

1400W dihydrochloride
B6730-50 50 mg
EUR 525.6
Description: 1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase with Kd value of 7 nM [1]. Inducible nitric oxide synthase (iNOS) is an enzyme catalyzing the production of nitric oxide (NO) and is involved in immune response.

Rimcazole dihydrochloride
B6765-10 10 mg
EUR 388.8

Rimcazole dihydrochloride
B6765-50 50 mg
EUR 1453.2

Zimelidine dihydrochloride
B6851-10 10 mg
EUR 212.4

Zimelidine dihydrochloride
B6851-50 50 mg
EUR 711.6

MPP dihydrochloride
B6910-10 10 mg
EUR 381.6

MPP dihydrochloride
B6910-50 50 mg
EUR 1413.6

Linopirdine dihydrochloride
B6916-10 10 mg
EUR 327.6

Linopirdine dihydrochloride
B6916-5 5 mg
EUR 224.4

Mizolastine dihydrochloride
B1116-100 100 mg
EUR 285.6
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions.

Mizolastine dihydrochloride
B1116-200 200 mg
EUR 468
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions.

Mizolastine dihydrochloride
B1116-500 500 mg
EUR 783.6
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions.

Flupenthixol dihydrochloride
B7578-50 50 mg
EUR 154.8
Description: MIC: 10-100 ?g/mL in most of the strainsFlupenthixol, introduced in 1965 by Lundbeck, marketed under brand names such asDepixol.Flupenthixolis atypical antipsychoticdrugof thethioxantheneclass.

Puromycin dihydrochloride
B7587-5.1 10 mM (in 1mL H2O)
EUR 142.8
Description: Puromycin dihydrochloride [1] is an analog of aminoacyl-tRNA.

Puromycin dihydrochloride
B7587-50 50 mg
EUR 157.2
Description: Puromycin dihydrochloride [1] is an analog of aminoacyl-tRNA.

Dexpramipexole dihydrochloride
B2215-25
EUR 548.4

Dexpramipexole dihydrochloride
B2215-5
EUR 183.6

Daclatasvir dihydrochloride
B2224-25
EUR 496.8

Daclatasvir dihydrochloride
B2224-5
EUR 170.4

Netarsudil dihydrochloride
B2387-25
EUR 548.4

Netarsudil dihydrochloride
B2387-5
EUR 183.6

Furamidine dihydrochloride
B2581-25
EUR 652.8

Furamidine dihydrochloride
B2581-5
EUR 210

Bisantrene dihydrochloride
B2736-25 25 mg
EUR 576

Bisantrene dihydrochloride
B2736-5 5 mg
EUR 199.2

Cystamine dihydrochloride
B2982-1 1 g
EUR 132

Cystamine dihydrochloride
B2982-5 5 g
EUR 351.6

Cetirizine dihydrochloride
B2993-100 100mg
EUR 132

Cetirizine dihydrochloride
B2993-500 500mg
EUR 344.4

SA4503 dihydrochloride
B3046-25 25 mg
EUR 612

SA4503 dihydrochloride
B3046-5 5 mg
EUR 199.2

Vanoxerine dihydrochloride
B3248-10 10 mg
EUR 141.6
Description: Vanoxerine is an antagonist of dopamine transporter (DAT1) with Ki value of 16.9nM [1].As an antagonist of DAT, vanoxerine is developed for treatment of Parkinson's disease and depression but has no effect on these diseases.

Vanoxerine dihydrochloride
B3248-25 25 mg
EUR 252
Description: Vanoxerine is an antagonist of dopamine transporter (DAT1) with Ki value of 16.9nM [1].As an antagonist of DAT, vanoxerine is developed for treatment of Parkinson's disease and depression but has no effect on these diseases.

Vanoxerine dihydrochloride
B3248-50 50 mg
EUR 398.4
Description: Vanoxerine is an antagonist of dopamine transporter (DAT1) with Ki value of 16.9nM [1].As an antagonist of DAT, vanoxerine is developed for treatment of Parkinson's disease and depression but has no effect on these diseases.

Spectinomycin dihydrochloride
B3342-1000 1 g
EUR 180
Description: Spectinomycin Dihydrochloride is a new parenteral antibiotic prepared from Streptomyces spectabilis.

Spectinomycin dihydrochloride
B3342-5.1 10 mM (in 1mL H2O)
EUR 201.6
Description: Spectinomycin Dihydrochloride is a new parenteral antibiotic prepared from Streptomyces spectabilis.

Spectinomycin dihydrochloride
B3342-5000 5 g
EUR 339.6
Description: Spectinomycin Dihydrochloride is a new parenteral antibiotic prepared from Streptomyces spectabilis.

Pentamidine dihydrochloride
B3416-50 50 mg
EUR 153.6
Description: Pentamidine Dihydrochloride(MP601205 dihydrochloride) is an antimicrobial agent.

Zoniporide dihydrochloride
B7160-10 10 mg
EUR 466.8

Zoniporide dihydrochloride
B7160-50 50 mg
EUR 1771.2

Cefotiam Dihydrochloride
C095-100MG 100 mg
EUR 278.4

Cefotiam Dihydrochloride
C095-50MG 50 mg
EUR 172.8

Chlorhexidine Dihydrochloride
C157-25G 25 g
EUR 222

Chlorhexidine Dihydrochloride
C157-5G 5 g
EUR 86.4

Antipain, dihydrochloride
ADJ692 5mg
EUR 110.53

Ethambutol dihydrochloride
E005-100G 100 g
EUR 508.8

Ethambutol dihydrochloride
E005-25G 25 g
EUR 171.6

Puromycin Dihydrochloride
P001-1G 1 g
EUR 604.8

Puromycin Dihydrochloride
P001-250MG 250 mg
EUR 192

Puromycin Dihydrochloride
P001-500MG 500 mg
EUR 342

Putrescine Dihydrochloride
P103-100G 100 g
EUR 188.4

Putrescine Dihydrochloride
P103-25G 25 g
EUR 67.2

Naftopidil Dihydrochloride
E1KS1387 25mg
EUR 296.4

Ethylenediamine dihydrochloride
GK6724-100G 100 g
EUR 64.8

Ethylenediamine dihydrochloride
GK6724-250G 250 g
EUR 103.2

Ethylenediamine dihydrochloride
GK6724-500G 500 g
EUR 141.6

1400W dihydrochloride
GK6799-100MG 100 mg
EUR 661.2

1400W dihydrochloride
GK6799-25MG 25 mg
EUR 274.8

1400W dihydrochloride
GK6799-5MG 5 mg
EUR 136.8

Hydroxyzine dihydrochloride
GK7844-10G 10 g
EUR 151.2

Cystamine dihydrochloride
GK9885-100G 100 g
EUR 98.4

Cystamine dihydrochloride
GK9885-250G 250 g
EUR 170.4

Cystamine dihydrochloride
GK9885-25G 25 g
EUR 60

SAG dihydrochloride
GL1175-1MG 1 mg
EUR 234

SAG dihydrochloride
GL1175-5MG 5 mg
EUR 688.8

Opipramol dihydrochloride
GL4485-100MG 100 mg
EUR 208.8

Opipramol dihydrochloride
GL4485-1G 1 g
EUR 753.6

Trifluoperazine dihydrochloride
GL5164-10G 10 g
EUR 132

Trifluoperazine dihydrochloride
GL5164-25G 25 g
EUR 223.2

Trifluoperazine dihydrochloride
GL5164-5G 5 g
EUR 93.6

Antipain dihydrochloride
GL6582-25MG 25 mg
EUR 282

Antipain dihydrochloride
GL6582-5MG 5 mg
EUR 136.8

Retigabine dihydrochloride
GP0386-100MG 100 mg
EUR 114

Retigabine dihydrochloride
GP0386-250MG 250 mg
EUR 166.8

Pirenzepine dihydrochloride
GP0823-1G 1 g
EUR 208.8

Pirenzepine dihydrochloride
GP0823-250MG 250 mg
EUR 93.6

Pirenzepine dihydrochloride
GP0823-500MG 500 mg
EUR 132

Octenidine dihydrochloride
GP2536-10G 10 g
EUR 180

Octenidine dihydrochloride
GP2536-1G 1 g
EUR 60

Octenidine dihydrochloride
GP2536-5G 5 g
EUR 117.6

Cetirizine dihydrochloride
GP4015-1G 1 g
EUR 79.2

Cetirizine dihydrochloride
GP4015-250MG 250 mg
EUR 62.4

Cetirizine dihydrochloride
GP4015-5G 5 g
EUR 132

Quinacrine (dihydrochloride)
HY-13735A 500mg
EUR 192

Sardomozide dihydrochloride
HY-13746B 10mM/1mL
EUR 271.2

Latrepirdine (dihydrochloride)
HY-14537 10mM/1mL
EUR 135.6

Inolitazone (dihydrochloride)
HY-14792B 5mg
EUR 652.8

Bavisant (dihydrochloride)
HY-14880A 5mg
EUR 391.2

PPACK Dihydrochloride